"immunotolerogenic" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "immuno",
        "3": "tolerogenic"
      },
      "expansion": "immuno- + tolerogenic",
      "name": "prefix"
    }
  ],
  "etymology_text": "From immuno- + tolerogenic.",
  "forms": [
    {
      "form": "more immunotolerogenic",
      "tags": [
        "comparative"
      ]
    },
    {
      "form": "most immunotolerogenic",
      "tags": [
        "superlative"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {},
      "expansion": "immunotolerogenic (comparative more immunotolerogenic, superlative most immunotolerogenic)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with immuno-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 November 17, “Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics”, in PLOS ONE, →DOI:",
          "text": "Studies in vitro showed that STn expression endowed bladder cancer cells with high invasion capability [5 ] and an immunotolerogenic phenotype, potentially favoring disease dissemination [6 ].",
          "type": "quote"
        }
      ],
      "glosses": [
        "That leads to immunotolerance"
      ],
      "id": "en-immunotolerogenic-en-adj-oTq~h6O9",
      "links": [
        [
          "immunotolerance",
          "immunotolerance"
        ]
      ]
    }
  ],
  "word": "immunotolerogenic"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "immuno",
        "3": "tolerogenic"
      },
      "expansion": "immuno- + tolerogenic",
      "name": "prefix"
    }
  ],
  "etymology_text": "From immuno- + tolerogenic.",
  "forms": [
    {
      "form": "more immunotolerogenic",
      "tags": [
        "comparative"
      ]
    },
    {
      "form": "most immunotolerogenic",
      "tags": [
        "superlative"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {},
      "expansion": "immunotolerogenic (comparative more immunotolerogenic, superlative most immunotolerogenic)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with immuno-",
        "English terms with quotations",
        "Pages with 1 entry",
        "Pages with entries"
      ],
      "examples": [
        {
          "ref": "2015 November 17, “Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics”, in PLOS ONE, →DOI:",
          "text": "Studies in vitro showed that STn expression endowed bladder cancer cells with high invasion capability [5 ] and an immunotolerogenic phenotype, potentially favoring disease dissemination [6 ].",
          "type": "quote"
        }
      ],
      "glosses": [
        "That leads to immunotolerance"
      ],
      "links": [
        [
          "immunotolerance",
          "immunotolerance"
        ]
      ]
    }
  ],
  "word": "immunotolerogenic"
}